nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—DRD4—Gilles de la Tourette syndrome	0.279	0.342	CbGaD
Lisuride—DRD3—Gilles de la Tourette syndrome	0.241	0.295	CbGaD
Lisuride—DRD2—Gilles de la Tourette syndrome	0.167	0.204	CbGaD
Lisuride—HTR2A—Gilles de la Tourette syndrome	0.129	0.158	CbGaD
Lisuride—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00272	0.0651	CbGeAlD
Lisuride—DRD4—brain—Gilles de la Tourette syndrome	0.00134	0.0321	CbGeAlD
Lisuride—DRD3—nervous system—Gilles de la Tourette syndrome	0.00123	0.0295	CbGeAlD
Lisuride—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00119	0.0284	CbGeAlD
Lisuride—DRD5—nervous system—Gilles de la Tourette syndrome	0.00116	0.0277	CbGeAlD
Lisuride—DRD5—central nervous system—Gilles de la Tourette syndrome	0.00111	0.0266	CbGeAlD
Lisuride—DRD1—midbrain—Gilles de la Tourette syndrome	0.00108	0.0257	CbGeAlD
Lisuride—Cabergoline—DRD4—Gilles de la Tourette syndrome	0.00107	0.149	CrCbGaD
Lisuride—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.000949	0.0227	CbGeAlD
Lisuride—DRD3—brain—Gilles de la Tourette syndrome	0.000944	0.0226	CbGeAlD
Lisuride—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.000928	0.0222	CbGeAlD
Lisuride—Cabergoline—DRD3—Gilles de la Tourette syndrome	0.000923	0.129	CrCbGaD
Lisuride—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.000913	0.0218	CbGeAlD
Lisuride—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.000893	0.0213	CbGeAlD
Lisuride—DRD5—brain—Gilles de la Tourette syndrome	0.000885	0.0211	CbGeAlD
Lisuride—DRD1—nervous system—Gilles de la Tourette syndrome	0.000884	0.0211	CbGeAlD
Lisuride—HTR1B—midbrain—Gilles de la Tourette syndrome	0.000872	0.0208	CbGeAlD
Lisuride—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000851	0.0203	CbGeAlD
Lisuride—HTR1D—midbrain—Gilles de la Tourette syndrome	0.000844	0.0202	CbGeAlD
Lisuride—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000836	0.02	CbGeAlD
Lisuride—Pergolide—DRD4—Gilles de la Tourette syndrome	0.000827	0.115	CrCbGaD
Lisuride—ADRA1B—brain—Gilles de la Tourette syndrome	0.000725	0.0173	CbGeAlD
Lisuride—HTR1B—nervous system—Gilles de la Tourette syndrome	0.000716	0.0171	CbGeAlD
Lisuride—Pergolide—DRD3—Gilles de la Tourette syndrome	0.000713	0.0994	CrCbGaD
Lisuride—ADRA1D—brain—Gilles de la Tourette syndrome	0.000709	0.0169	CbGeAlD
Lisuride—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000703	0.0168	CbGeAlD
Lisuride—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000694	0.0166	CbGeAlD
Lisuride—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.00069	0.0165	CbGeAlD
Lisuride—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000687	0.0164	CbGeAlD
Lisuride—DRD1—brain—Gilles de la Tourette syndrome	0.000676	0.0162	CbGeAlD
Lisuride—ADRB1—nervous system—Gilles de la Tourette syndrome	0.000674	0.0161	CbGeAlD
Lisuride—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.000668	0.016	CbGeAlD
Lisuride—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000661	0.0158	CbGeAlD
Lisuride—ADRB1—central nervous system—Gilles de la Tourette syndrome	0.000649	0.0155	CbGeAlD
Lisuride—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000645	0.0154	CbGeAlD
Lisuride—Cabergoline—DRD2—Gilles de la Tourette syndrome	0.000639	0.089	CrCbGaD
Lisuride—DRD2—midbrain—Gilles de la Tourette syndrome	0.000635	0.0152	CbGeAlD
Lisuride—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000621	0.0148	CbGeAlD
Lisuride—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000618	0.0148	CbGeAlD
Lisuride—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000578	0.0138	CbGeAlD
Lisuride—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000557	0.0133	CbGeAlD
Lisuride—HTR1B—brain—Gilles de la Tourette syndrome	0.000548	0.0131	CbGeAlD
Lisuride—HTR1D—brain—Gilles de la Tourette syndrome	0.00053	0.0127	CbGeAlD
Lisuride—HTR2C—brain—Gilles de la Tourette syndrome	0.000525	0.0125	CbGeAlD
Lisuride—DRD2—nervous system—Gilles de la Tourette syndrome	0.000522	0.0125	CbGeAlD
Lisuride—ADRB1—brain—Gilles de la Tourette syndrome	0.000515	0.0123	CbGeAlD
Lisuride—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000508	0.0121	CbGeAlD
Lisuride—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000503	0.012	CbGeAlD
Lisuride—Pergolide—DRD2—Gilles de la Tourette syndrome	0.000493	0.0688	CrCbGaD
Lisuride—Cabergoline—HTR2A—Gilles de la Tourette syndrome	0.000493	0.0688	CrCbGaD
Lisuride—Methylergometrine—HTR2A—Gilles de la Tourette syndrome	0.000493	0.0688	CrCbGaD
Lisuride—HTR2B—brain—Gilles de la Tourette syndrome	0.000493	0.0118	CbGeAlD
Lisuride—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000493	0.0118	CbGeAlD
Lisuride—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000489	0.0117	CbGeAlD
Lisuride—HTR1A—brain—Gilles de la Tourette syndrome	0.000442	0.0106	CbGeAlD
Lisuride—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000419	0.01	CbGeAlD
Lisuride—Methysergide—HTR2A—Gilles de la Tourette syndrome	0.000412	0.0574	CrCbGaD
Lisuride—Ergotamine—DRD2—Gilles de la Tourette syndrome	0.000411	0.0573	CrCbGaD
Lisuride—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000405	0.00968	CbGeAlD
Lisuride—DRD2—brain—Gilles de la Tourette syndrome	0.000399	0.00954	CbGeAlD
Lisuride—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.00039	0.00932	CbGeAlD
Lisuride—ADRA2C—brain—Gilles de la Tourette syndrome	0.000388	0.00928	CbGeAlD
Lisuride—Pergolide—HTR2A—Gilles de la Tourette syndrome	0.000381	0.0531	CrCbGaD
Lisuride—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000345	0.00823	CbGeAlD
Lisuride—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000332	0.00793	CbGeAlD
Lisuride—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000319	0.00762	CbGeAlD
Lisuride—Ergotamine—HTR2A—Gilles de la Tourette syndrome	0.000318	0.0443	CrCbGaD
Lisuride—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000314	0.0075	CbGeAlD
Lisuride—ADRA2A—brain—Gilles de la Tourette syndrome	0.00031	0.0074	CbGeAlD
Lisuride—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000307	0.00734	CbGeAlD
Lisuride—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000302	0.00722	CbGeAlD
Lisuride—HTR2A—brain—Gilles de la Tourette syndrome	0.000263	0.00629	CbGeAlD
Lisuride—CYP2D6—brain—Gilles de la Tourette syndrome	0.00024	0.00573	CbGeAlD
Lisuride—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6e-05	0.000444	CbGpPWpGaD
Lisuride—DRD5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.97e-05	0.000441	CbGpPWpGaD
Lisuride—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.86e-05	0.000433	CbGpPWpGaD
Lisuride—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.86e-05	0.000433	CbGpPWpGaD
Lisuride—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.84e-05	0.000432	CbGpPWpGaD
Lisuride—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.84e-05	0.000432	CbGpPWpGaD
Lisuride—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.83e-05	0.000431	CbGpPWpGaD
Lisuride—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.83e-05	0.000431	CbGpPWpGaD
Lisuride—DRD5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.79e-05	0.000429	CbGpPWpGaD
Lisuride—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.76e-05	0.000426	CbGpPWpGaD
Lisuride—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.76e-05	0.000426	CbGpPWpGaD
Lisuride—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.75e-05	0.000425	CbGpPWpGaD
Lisuride—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.7e-05	0.000422	CbGpPWpGaD
Lisuride—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.67e-05	0.000419	CbGpPWpGaD
Lisuride—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.67e-05	0.000419	CbGpPWpGaD
Lisuride—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.65e-05	0.000418	CbGpPWpGaD
Lisuride—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	5.63e-05	0.000417	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	5.6e-05	0.000414	CbGpPWpGaD
Lisuride—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.58e-05	0.000413	CbGpPWpGaD
Lisuride—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.58e-05	0.000413	CbGpPWpGaD
Lisuride—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.46e-05	0.000404	CbGpPWpGaD
Lisuride—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.43e-05	0.000402	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.42e-05	0.000401	CbGpPWpGaD
Lisuride—DRD5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.4e-05	0.000399	CbGpPWpGaD
Lisuride—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.3e-05	0.000392	CbGpPWpGaD
Lisuride—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.28e-05	0.000391	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.26e-05	0.000389	CbGpPWpGaD
Lisuride—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.25e-05	0.000388	CbGpPWpGaD
Lisuride—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.21e-05	0.000386	CbGpPWpGaD
Lisuride—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.2e-05	0.000385	CbGpPWpGaD
Lisuride—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.2e-05	0.000384	CbGpPWpGaD
Lisuride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.14e-05	0.00038	CbGpPWpGaD
Lisuride—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.14e-05	0.00038	CbGpPWpGaD
Lisuride—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.12e-05	0.000379	CbGpPWpGaD
Lisuride—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.06e-05	0.000374	CbGpPWpGaD
Lisuride—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.02e-05	0.000371	CbGpPWpGaD
Lisuride—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.02e-05	0.000371	CbGpPWpGaD
Lisuride—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.99e-05	0.000369	CbGpPWpGaD
Lisuride—DRD4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.94e-05	0.000365	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.9e-05	0.000363	CbGpPWpGaD
Lisuride—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.86e-05	0.000359	CbGpPWpGaD
Lisuride—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.78e-05	0.000354	CbGpPWpGaD
Lisuride—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	4.74e-05	0.000351	CbGpPWpGaD
Lisuride—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.71e-05	0.000349	CbGpPWpGaD
Lisuride—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.71e-05	0.000349	CbGpPWpGaD
Lisuride—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	4.6e-05	0.000341	CbGpPWpGaD
Lisuride—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4.6e-05	0.000341	CbGpPWpGaD
Lisuride—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.57e-05	0.000338	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	4.55e-05	0.000336	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.48e-05	0.000331	CbGpPWpGaD
Lisuride—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.44e-05	0.000329	CbGpPWpGaD
Lisuride—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.44e-05	0.000328	CbGpPWpGaD
Lisuride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.41e-05	0.000326	CbGpPWpGaD
Lisuride—DRD4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.4e-05	0.000326	CbGpPWpGaD
Lisuride—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.39e-05	0.000324	CbGpPWpGaD
Lisuride—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.39e-05	0.000324	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.35e-05	0.000321	CbGpPWpGaD
Lisuride—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.29e-05	0.000317	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.2e-05	0.000311	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.15e-05	0.000307	CbGpPWpGaD
Lisuride—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.13e-05	0.000306	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.08e-05	0.000302	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.06e-05	0.000301	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.05e-05	0.000299	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.03e-05	0.000298	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4e-05	0.000296	CbGpPWpGaD
Lisuride—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4e-05	0.000296	CbGpPWpGaD
Lisuride—DRD4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.98e-05	0.000295	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.97e-05	0.000293	CbGpPWpGaD
Lisuride—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.96e-05	0.000293	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.95e-05	0.000292	CbGpPWpGaD
Lisuride—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	3.94e-05	0.000292	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.91e-05	0.000289	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.85e-05	0.000285	CbGpPWpGaD
Lisuride—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.82e-05	0.000283	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.82e-05	0.000282	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.8e-05	0.000281	CbGpPWpGaD
Lisuride—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.8e-05	0.000281	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.8e-05	0.000281	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.8e-05	0.000281	CbGpPWpGaD
Lisuride—DRD5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.78e-05	0.00028	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.75e-05	0.000278	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.71e-05	0.000274	CbGpPWpGaD
Lisuride—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.7e-05	0.000274	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.68e-05	0.000272	CbGpPWpGaD
Lisuride—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.64e-05	0.000269	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.62e-05	0.000268	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.6e-05	0.000266	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.59e-05	0.000265	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.56e-05	0.000264	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.55e-05	0.000263	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.54e-05	0.000262	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.54e-05	0.000262	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.53e-05	0.000261	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.5e-05	0.000259	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.46e-05	0.000256	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.45e-05	0.000255	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.45e-05	0.000255	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.45e-05	0.000255	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.43e-05	0.000254	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.43e-05	0.000254	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.41e-05	0.000252	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.39e-05	0.000251	CbGpPWpGaD
Lisuride—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.36e-05	0.000248	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.31e-05	0.000245	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.3e-05	0.000244	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.29e-05	0.000244	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.26e-05	0.000241	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.25e-05	0.00024	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.24e-05	0.000239	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.22e-05	0.000238	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.21e-05	0.000238	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.21e-05	0.000238	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.21e-05	0.000237	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.2e-05	0.000237	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.2e-05	0.000237	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.19e-05	0.000236	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.15e-05	0.000233	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.14e-05	0.000232	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.11e-05	0.00023	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.11e-05	0.00023	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.1e-05	0.000229	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.08e-05	0.000228	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.08e-05	0.000228	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.07e-05	0.000227	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.01e-05	0.000222	CbGpPWpGaD
Lisuride—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3e-05	0.000222	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3e-05	0.000222	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.99e-05	0.000221	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.99e-05	0.000221	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.98e-05	0.000221	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	2.96e-05	0.000219	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.95e-05	0.000218	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.95e-05	0.000218	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.94e-05	0.000217	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.93e-05	0.000217	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.91e-05	0.000215	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.91e-05	0.000215	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.9e-05	0.000215	CbGpPWpGaD
Lisuride—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.9e-05	0.000214	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.9e-05	0.000214	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.86e-05	0.000212	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.86e-05	0.000212	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.84e-05	0.00021	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.8e-05	0.000207	CbGpPWpGaD
Lisuride—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.79e-05	0.000206	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.79e-05	0.000206	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.72e-05	0.000201	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.71e-05	0.0002	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.68e-05	0.000198	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.68e-05	0.000198	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.67e-05	0.000197	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.66e-05	0.000197	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.66e-05	0.000197	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.64e-05	0.000195	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.63e-05	0.000194	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.6e-05	0.000192	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.6e-05	0.000192	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.57e-05	0.00019	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.53e-05	0.000187	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.51e-05	0.000186	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.48e-05	0.000183	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.48e-05	0.000183	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.45e-05	0.000181	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.43e-05	0.00018	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.42e-05	0.000179	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.42e-05	0.000179	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.42e-05	0.000179	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.4e-05	0.000178	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.38e-05	0.000176	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.36e-05	0.000175	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.36e-05	0.000175	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.33e-05	0.000172	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.28e-05	0.000169	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.26e-05	0.000167	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.26e-05	0.000167	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.25e-05	0.000166	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.25e-05	0.000166	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.24e-05	0.000165	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.22e-05	0.000164	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.2e-05	0.000163	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.19e-05	0.000162	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.17e-05	0.000161	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.16e-05	0.00016	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.15e-05	0.000159	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.14e-05	0.000158	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.13e-05	0.000157	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.1e-05	0.000155	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.09e-05	0.000155	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.07e-05	0.000153	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.06e-05	0.000152	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.05e-05	0.000152	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.04e-05	0.000151	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.04e-05	0.000151	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.04e-05	0.000151	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.03e-05	0.00015	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.03e-05	0.00015	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.96e-05	0.000145	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.95e-05	0.000144	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	1.94e-05	0.000143	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.92e-05	0.000142	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.91e-05	0.000141	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.9e-05	0.00014	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.9e-05	0.00014	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.9e-05	0.00014	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.9e-05	0.00014	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.89e-05	0.00014	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.87e-05	0.000138	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.86e-05	0.000137	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.84e-05	0.000136	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.83e-05	0.000135	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.82e-05	0.000135	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.78e-05	0.000131	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.77e-05	0.000131	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.77e-05	0.000131	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.74e-05	0.000129	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.73e-05	0.000128	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.72e-05	0.000127	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.72e-05	0.000127	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.71e-05	0.000127	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.7e-05	0.000126	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.69e-05	0.000125	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.65e-05	0.000122	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.65e-05	0.000122	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.61e-05	0.000119	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.6e-05	0.000118	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.58e-05	0.000117	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.58e-05	0.000117	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.56e-05	0.000115	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.55e-05	0.000115	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.54e-05	0.000114	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.53e-05	0.000113	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.52e-05	0.000112	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.5e-05	0.000111	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.44e-05	0.000106	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.43e-05	0.000106	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.43e-05	0.000106	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.4e-05	0.000103	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.35e-05	9.97e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.33e-05	9.83e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.33e-05	9.83e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.3e-05	9.62e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.21e-05	8.96e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.2e-05	8.88e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.16e-05	8.57e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.15e-05	8.53e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.12e-05	8.29e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.1e-05	8.16e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.02e-05	7.52e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.11e-06	6.74e-05	CbGpPWpGaD
